Sareum Hldgs Plc - Asset Resilience Ratio

Latest as of June 2019: 0.00%

Sareum Hldgs Plc (SAR) has an Asset Resilience Ratio of 0.00% as of June 2019. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See SAR current assets to equity ratio to evaluate short-term liquidity relative to the company's equity base.

Liquid Assets

GBX1.00

≈ $0.00 USD Cash + Short-term Investments

Total Assets

GBX1.24 Million

≈ $151.01 USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2014–2021)

This chart shows how Sareum Hldgs Plc's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see SAR current and non-current assets.

Liquid Assets Composition Over Time

This chart breaks down Sareum Hldgs Plc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Explore how much of Sareum Hldgs Plc's assets are long-term investments to see how much of total assets are deployed in long-term investments.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	GBX0.00	0%
Short-term Investments	GBX1.00	0.0%
Total Liquid Assets	GBX1.00	0.00%

Asset Resilience Insights

Limited Liquidity: Sareum Hldgs Plc maintains only 0.00% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Sareum Hldgs Plc Industry Peers by Asset Resilience Ratio

Compare Sareum Hldgs Plc's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
ALK-Abelló A/S CO:ALK-B	Biotechnology	0.98%
Mirum Pharmaceuticals Inc NASDAQ:MIRM	Biotechnology	6.89%
Xiamen Amoytop Biotech Co Ltd SHG:688278	Biotechnology	4.69%
BB Biotech AG SW:BION	Biotechnology	92.97%
Soleno Therapeutics Inc NASDAQ:SLNO	Biotechnology	20.15%
Nanobiotix NASDAQ:NBTX	Biotechnology	4.71%
Wuhan Keqian Biology Co Ltd SHG:688526	Biotechnology	19.42%
Beijing Konruns Pharmaceutical Co Ltd SHG:603590	Biotechnology	10.55%

Annual Asset Resilience Ratio for Sareum Hldgs Plc (2014–2021)

The table below shows the annual Asset Resilience Ratio data for Sareum Hldgs Plc.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2021-06-30	87.24%	GBX2.69 Million ≈ $326.83	GBX3.08 Million ≈ $374.65	-2.39pp
2020-06-30	89.63%	GBX1.79 Million ≈ $218.34	GBX2.00 Million ≈ $243.60	+89.63pp
2019-06-30	0.00%	GBX1.00 ≈ $0.00	GBX1.24 Million ≈ $151.01	-75.37pp
2018-06-30	75.37%	GBX1.37 Million ≈ $166.53	GBX1.82 Million ≈ $220.96	-16.45pp
2017-06-30	91.82%	GBX2.30 Million ≈ $279.41	GBX2.50 Million ≈ $304.32	+80.63pp
2014-06-30	11.18%	GBX200.00K ≈ $24.33	GBX1.79 Million ≈ $217.58	--

pp = percentage points

About Sareum Hldgs Plc

LSE:SAR UK Biotechnology

Market Cap

$505.78K

GBX4.16 Billion GBX

Market Cap Rank

#31063 Global

#927 in UK

Share Price

GBX30.00

Change (1 day)

+1.69%

52-Week Range

GBX12.00 - GBX37.00

All Time High

GBX457.50